BusinessActinium Pharmaceuticals Highlights Presence at Upcoming Society of Nuclear Medicine and Molecular Imaging Annual MeetingBy Nasdaq OMXJun 8, 2017, 11:30 AM UTC
BusinessUPDATE – Actinium Pharmaceuticals to Host Webinar on June 12th to Update on Pivotal Phase 3 SIERRA Clinical Trial for Iomab-BBy Nasdaq OMXJun 8, 2017, 11:00 AM UTC
BusinessActinium Pharmaceuticals to Host Webinar on June 12th to Update on Pivotal Phase 3 SIERRA Clinical Trial for Iomab-BBy Nasdaq OMXMay 31, 2017, 11:37 AM UTC
BusinessActinium Pharmaceuticals to Host Webinar on June 12th to Update on Pivotal Phase 3 SIERRA Clinical Trial for Iomab-BBy Nasdaq OMXMay 31, 2017, 11:36 AM UTC
BusinessActinium Pharmaceuticals to Host Webinar on June 12th to Update on Pivotal Phase 3 SIERRA Clinical Trial for Iomab-BBy Nasdaq OMXMay 31, 2017, 11:36 AM UTC
BusinessActinium Pharmaceuticals to Host Webinar on June 12th to Update on Pivotal Phase 3 SIERRA Clinical Trial for Iomab-BBy Nasdaq OMXMay 31, 2017, 11:36 AM UTC
BusinessActinium Pharmaceuticals to Host Webinar on June 12th to Update on Pivotal Phase 3 SIERRA Clinical Trial for Iomab-BBy Nasdaq OMXMay 31, 2017, 11:36 AM UTC
BusinessActinium Pharmaceuticals to Host Webinar on June 12th to Update on Pivotal Phase 3 SIERRA Clinical Trial for Iomab-BBy Nasdaq OMXMay 31, 2017, 11:36 AM UTC
